ZNF503 combined with GATA3 is a prognostic factor in triple-negative breast cancer.

MLA

Liu, Siyu, et al. “ZNF503 Combined with GATA3 Is a Prognostic Factor in Triple-Negative Breast Cancer.” Biomarkers, vol. 28, no. 5, July 2023, pp. 437–47. EBSCOhost, https://doi.org/10.1080/1354750X.2023.2201665.

APA

Liu, S., Cao, X., Li, J., & Liu, J. (2023). ZNF503 combined with GATA3 is a prognostic factor in triple-negative breast cancer. Biomarkers, 28(5), 437–447. https://doi.org/10.1080/1354750X.2023.2201665

Chicago

Liu, Siyu, Xiaobin Cao, Jing Li, and Jingjing Liu. 2023. “ZNF503 Combined with GATA3 Is a Prognostic Factor in Triple-Negative Breast Cancer.” Biomarkers 28 (5): 437–47. doi:10.1080/1354750X.2023.2201665.